Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
OTC Markets
22:48:55 08/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.84M 1.74M 1.58M 2.96M 204M 2.98M 20.8M 8M 104M 7.99M 7.82M 330M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.84M 5.52M 5M 9.38M 647M 9.46M 65.91M 25.36M 328M 25.33M 24.77M 1.05B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +9,900.00% | 0.00% | 2.13K | ||
| -2.53% | -8.63% | -25.34% | +21.18% | 3.11B | ||
| -2.36% | -4.61% | +25.91% | +1,517.19% | 2.95B | ||
| +4.91% | +0.33% | +60.02% | +466.55% | 2.66B | ||
| -0.44% | -6.86% | -33.67% | -17.57% | 1.68B | ||
| +1.05% | -3.03% | +123.26% | +464.71% | 1.45B | ||
| -5.92% | -9.21% | -9.58% | +7.25% | 575M | ||
| +0.23% | -0.97% | +15.12% | +38.83% | 338M | ||
| -1.10% | -9.40% | +29.19% | +41.36% | 190M | ||
| -0.77% | -4.44% | +29.00% | +69.74% | 112M | ||
| Average | -0.69% | -2.84% | +1,011.39% | +260.92% | 1.31B | |
| Weighted average by Cap. | -0.35% | -4.49% | +22.01% | +494.03% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.28M 13.5M 12.22M 22.94M 1.58B 23.11M 161M 61.99M 802M 61.92M 60.55M 2.56B | 14.01M 12.14M 11.48M 10.39M 19.5M 1.34B 19.65M 137M 52.69M 682M 52.63M 51.47M 2.17B |
| Net income | -4.29M -3.72M -3.52M -3.18M -5.97M -412M -6.02M -41.95M -16.14M -209M -16.12M -15.76M -666M | -7.61M -6.59M -6.23M -5.64M -10.59M -730M -10.67M -74.36M -28.61M -370M -28.58M -27.94M -1.18B |
| Net Debt | 3.04M 2.64M 2.49M 2.26M 4.24M 292M 4.27M 29.74M 11.44M 148M 11.43M 11.18M 472M | 4.62M 4M 3.78M 3.42M 6.42M 443M 6.47M 45.11M 17.35M 224M 17.34M 16.95M 716M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















